New developments in atrial antiarrhythmic drug therapy
A Burashnikov, C Antzelevitch - Nature Reviews Cardiology, 2010 - nature.com
Atrial fibrillation (AF) is a growing clinical problem associated with increased morbidity and
mortality. Currently available antiarrhythmic drugs (AADs), although highly effective in acute …
mortality. Currently available antiarrhythmic drugs (AADs), although highly effective in acute …
Targeting the arrhythmogenic substrate in atrial fibrillation: focus on structural remodeling
E Raschi, G Boriani, F De Ponti - Current drug targets, 2011 - ingentaconnect.com
Atrial fibrillation (AF) is an emerging clinical problem with multifaceted issues: current and
expected prevalence, significant morbidity, potentially fatal outcome (eg, stroke) and gaps in …
expected prevalence, significant morbidity, potentially fatal outcome (eg, stroke) and gaps in …
Aliskiren protecting atrial structural remodeling from rapid atrial pacing in a canine model
Z Zhao, Y Chen, W Li, X Wang, J Li, W Yang… - Naunyn-Schmiedeberg's …, 2016 - Springer
Atrial fibrillation (AF) contributing to the increasing mortality risk is the most common disease
in clinical practice. Owing to the side effects and relative inefficacy of current antiarrhythmic …
in clinical practice. Owing to the side effects and relative inefficacy of current antiarrhythmic …
血管紧张素受体拮抗剂在心房颤动中的作用: 启示与困惑
冯颖青 - 中华高血压杂志, 2012 - cqvip.com
心房颤动是最常见的心律失常, 人群患病率约为0.4%~ 1.0%. 随着社会人口老龄化的到来,
心房颤动的患病率也随之增加, 心房颤动导致脑卒中, 心力衰竭和死亡的增加 …
心房颤动的患病率也随之增加, 心房颤动导致脑卒中, 心力衰竭和死亡的增加 …
Remodelages électriques et structurels prédisposant à la fibrillation auriculaire dans un modèle murin de surexpression du récepteur de type 1 à l'angiotensine II
J Demers - 2021 - papyrus.bib.umontreal.ca
La fibrillation auriculaire (FA) est l'arythmie cardiaque soutenue la plus fréquente et elle peut
mener à des conséquences médicales sévères, comme les accidents vasculaires cérébraux …
mener à des conséquences médicales sévères, comme les accidents vasculaires cérébraux …
WITHDRAWN: Expression of the angiotensin II, rac GTPase activating protein 1, signal transducer and activator of transcription 3 signaling pathway in patients with …
W Yan, C Xuan, J Ge, H Zhang… - Molecular medicine …, 2015 - pubmed.ncbi.nlm.nih.gov
WITHDRAWN:Expression of the angiotensin II, rac GTPase activating protein 1, signal
transducer and activator of transcription 3 signaling pathway in patients with permanent atrial …
transducer and activator of transcription 3 signaling pathway in patients with permanent atrial …